MEK1 (MAP2K1) Capture Mouse Monoclonal Antibody [Clone ID: OTI1A10]

CAT#: TA600341

MAP2K1 Capture mouse monoclonal antibody, ELISA and Luminex validated, clone OTI1A10

Product Images

MAP2K1 Elisa with 1A10 Capture (TA600341) and 2B2 Detection (TA700335) Antibodies. Substrate used: Recombinant Human MAP2K1 (TP318460)

• 

  MAP2K1 Luminex Elisa with 1A10 Capture (TA600341) and 2B2 Detection (TA700335) Antibodies. Substrate used: Recombinant Human MAP2K1 (TP318460)

Specifications

Product Data

• Clone Name: OTI1A10
• Applications: ELISA, LMNX
• Recommended Dilution: 1:100 - 1:1000
• Reactivities: Human, Mouse, Rat
• Host: Mouse
• Isotype: IgG1
• Clonality: Monoclonal
• Immunogen: Full length human recombinant protein of human MAP2K1 (NM_002755) produced in HEK293T cell.
• Formulation: Stored in PBS (pH 7.4) containing 0.05% sodium azide and up to 5% trehalose
• Concentration: 0.5 mg/ml
• Conjugation: Unconjugated
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Gene Name: mitogen-activated protein kinase kinase 1
• Database Link:
  NP_002746
  Entrez Gene 26395 MouseEntrez Gene 170851 RatEntrez Gene 5604 Human
  UniProt ID Q02750
• Synonyms: CFC3; MAPKK1; MEK1; MKK1; PRKMK1
• Matched ELISA Pair: TA700335

Reference Data

• Protein Families: Druggable Genome, Protein Kinase
• Protein Pathways: Acute myeloid leukemia, B cell receptor signaling pathway, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Dorso-ventral axis formation, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, Gap junction, Glioma, GnRH signaling pathway, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Oocyte meiosis, Pancreatic cancer, Pathways in cancer, Prion diseases, Progesterone-mediated oocyte maturation, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, T cell receptor signaling pathway, Thyroid cancer, Toll-like receptor signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway